Reports
Report previews for internal review.
Last 30 days. Each preview reads from the same aggregate analytics layer. Export is not part of this phase.
Product performance
Tracked sessions, reported effectiveness, side-effect rate
Tinroof481 sessions · 4.2 / 5 · 33.3%
Colour of Space339 sessions · 3.9 / 5 · 36.6%
Apple Fritter277 sessions · 3.9 / 5 · 29.6%
3 medicines meet the minimum sample rule
Batch quality signals
Deviations from the product average
AM2501 · TinroofNo reportable deviation
AM2505 · TinroofNo reportable deviation
AM2506 · Colour of SpaceNo reportable deviation
AM2502 · Colour of Space1 signal(s)
AM2507 · Colour of SpaceNo reportable deviation
AM2504 · TinroofNo reportable deviation
AM2509 · Apple FritterNo reportable deviation
AM2508 · Apple FritterNo reportable deviation
AM2503 · Apple Fritter1 signal(s)
AM2510 · Tinroof1 signal(s)
10 batches compared
Patient-reported outcomes
Aggregate outcome summary
Tracked sessions1,097
Unique tracked patients391
Average reported effectiveness4.0 / 5
Side-effect rate33.4%
Continued tracking rate75%
Not good0%Below average0%Neutral28%Good42%Very good30%
Effect / side-effect summary
Top reported items
Reported effects
Relaxed37%
Calm31%
Better Mood26%
Focused21%
Pain Relief20%
Reported side effects
Dry Mouth14%
Drowsiness9%
Dry Eyes9%
Dizziness4%
Anxiety / Paranoia3%
Tracking engagement
Weekly tracked sessions
16 Jul023 Jul030 Jul006 Aug6813 Aug25420 Aug25027 Aug26503 Sept260
1 session25% · 99
2–3 sessions42% · 163
4–10 sessions33% · 129
10+ sessions0% · 0
Report previews summarise aggregate reported experience. They contain no patient identities, no free-text notes, and no clinical or dosing recommendations.